Gelesis Holdings, Inc. (GLSHQ)
USD 0.0
(-79.0%)
USD 0.0
(-79.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | -1.79 Million USD | -249.0% |
| 2021 | 1.2 Million USD | 0.0% |
| 2020 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | 609 Thousand USD | 18.02% |
| 2023 Q1 | 516 Thousand USD | 104.44% |
| 2022 FY | -1.79 Million USD | -249.0% |
| 2022 Q4 | -11.61 Million USD | -482.58% |
| 2022 Q3 | 3.03 Million USD | -27.49% |
| 2022 Q2 | 4.18 Million USD | 60.98% |
| 2022 Q1 | 2.6 Million USD | 427.59% |
| 2021 Q1 | 285 Thousand USD | 0.0% |
| 2021 Q3 | 251 Thousand USD | 45.09% |
| 2021 Q2 | 173 Thousand USD | -39.3% |
| 2021 FY | 1.2 Million USD | 0.0% |
| 2021 Q4 | 493 Thousand USD | 96.41% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -73331.734% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 115.3% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -460.551% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 101.504% |
| Qrons Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 93.058% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -3611.225% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -1341.437% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 111.941% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 57836.944% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 118.287% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 2824.866% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -5144.51% |
| Mesoblast Limited | -35.16 Million USD | 94.907% |
| Marizyme, Inc. | 457.7 Thousand USD | 491.303% |
| Genus plc | 178.7 Million USD | 101.002% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.814% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 2978.218% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 536.654% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -16181.818% |
| ContraFect Corporation | -154 Thousand USD | -1062.987% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -3482.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 2433.216% |
| IMV Inc. | -962.29 Thousand USD | -86.117% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -362.192% |
| MultiCell Technologies, Inc. | 49.32 USD | 3631486.861% |
| ONE Bio Corp. | 20.12 Million USD | 108.899% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 104.448% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 3762.577% |
| Q BioMed Inc. | -8988.00 USD | -19826.569% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 106.339% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -11511.774% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 104.038% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | -56.889% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 2658.571% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -36067.205% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 1374.733% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -1736.641% |
| GB Sciences, Inc. | -624.00 USD | -286919.231% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -1981.88% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.024% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -860957.692% |
| Enzolytics Inc. | 30.7 Thousand USD | 5932.356% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 471.243% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.162% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | -248.098% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 390.095% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.437% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -20123.577% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -2035.983% |
| Kadimastem Ltd | -630.13 Thousand USD | -184.223% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 281.279% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 118.635% |
| BioStem Technologies, Inc. | 15.42 Million USD | 111.611% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -15033.08% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 1114.386% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 1114.386% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 231.968% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -6075.862% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 497.962% |
| SYBLEU INC | 11.69 Thousand USD | 15412.927% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 138.867% |
| Bioxytran, Inc. | -8285.00 USD | -21517.381% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -380.161% |
| Neutra Corp. | 14.33 Thousand USD | 12593.896% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -2084.146% |
| PureTech Health plc | -1.6 Million USD | -11.728% |
| Coeptis Therapeutics, Inc. | -1 Million USD | -78.879% |
| IXICO plc | 3.27 Million USD | 154.771% |
| IntelGenx Technologies Corp. | -694 Thousand USD | -158.069% |
| CSL Limited | 7.7 Billion USD | 100.023% |
| Cellectis S.A. | 18 Thousand USD | 10050.0% |